Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jonathan Chang is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/13/2025 | GMAB | Buy Now | Genmab | $19.66 | 37.33% | Jonathan Chang38% | → $27 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/08/2024 | VINC | Buy Now | Vincerx Pharma | $0.59 | 239.1% | Jonathan Chang38% | $80 → $40 | Maintains | Outperform | Get Alert |
| 04/29/2024 | IMCR | Buy Now | Immunocore Hldgs | $29.47 | 151.1% | Jonathan Chang38% | → $74 | Initiates | → Outperform | Get Alert |
| 12/08/2023 | NBTX | Buy Now | Nanobiotix | $3.65 | 201.37% | Jonathan Chang38% | → $11 | Initiates | → Outperform | Get Alert |
| 08/04/2023 | NVCR | Buy Now | NovoCure | $18.44 | 176.57% | Jonathan Chang38% | → $51 | Initiates | → Outperform | Get Alert |
| 01/10/2023 | KPTI | Buy Now | Karyopharm Therapeutics | $5.60 | -10.71% | Jonathan Chang38% | $90 → $75 | Maintains | Market Perform | Get Alert |
| 12/07/2022 | REPL | Buy Now | Replimune Group | $10.40 | 226.92% | Jonathan Chang38% | $30 → $34 | Maintains | Outperform | Get Alert |
| 11/30/2022 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Jonathan Chang38% | → $6 | Initiates | → Outperform | Get Alert |
| 11/30/2022 | PNT | Buy Now | POINT Biopharma Global | — | — | Jonathan Chang38% | → $14 | Initiates | → Outperform | Get Alert |
| 11/15/2022 | CALA | Buy Now | Calithera Biosciences | $0.00 | 249900% | Jonathan Chang38% | $18 → $2 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/15/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | Jonathan Chang38% | $100 → $40 | Maintains | Outperform | Get Alert |
| 11/10/2022 | GMAB | Buy Now | Genmab | $19.66 | 67.85% | Jonathan Chang38% | $31 → $33 | Maintains | Market Perform | Get Alert |
| 11/08/2022 | TCRR | Buy Now | TCR2 Therapeutics | — | — | Jonathan Chang38% | $3 → $2 | Maintains | Market Perform | Get Alert |
| 11/04/2022 | KPTI | Buy Now | Karyopharm Therapeutics | $5.60 | 7.14% | Jonathan Chang38% | $75 → $90 | Maintains | Market Perform | Get Alert |
| 10/03/2022 | REPL | Buy Now | Replimune Group | $10.40 | 188.46% | Jonathan Chang38% | $37 → $30 | Maintains | Outperform | Get Alert |
| 08/22/2022 | BCYC | Buy Now | Bicycle Therapeutics | $8.73 | 472.74% | Jonathan Chang38% | $48 → $50 | Maintains | Outperform | Get Alert |
| 08/16/2022 | CALA | Buy Now | Calithera Biosciences | $0.00 | 2249900% | Jonathan Chang38% | $2 → $18 | Maintains | Outperform | Get Alert |
| 08/12/2022 | VINC | Buy Now | Vincerx Pharma | $0.59 | 747.74% | Jonathan Chang38% | $120 → $100 | Maintains | Outperform | Get Alert |
| 08/11/2022 | GMAB | Buy Now | Genmab | $19.66 | 57.68% | Jonathan Chang38% | $30 → $31 | Maintains | Market Perform | Get Alert |
| 08/11/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | Jonathan Chang38% | $130 → $100 | Maintains | Outperform | Get Alert |
| 08/10/2022 | RVMD | Buy Now | Revolution Medicines | $37.72 | -20.47% | Jonathan Chang38% | $31 → $30 | Maintains | Outperform | Get Alert |
| 08/09/2022 | MGNX | Buy Now | Macrogenics | $1.57 | 664.33% | Jonathan Chang38% | $15 → $12 | Maintains | Outperform | Get Alert |
| 08/09/2022 | RUBY | Buy Now | Rubius Therapeutics | — | — | Jonathan Chang38% | $2 → $1 | Maintains | Market Perform | Get Alert |
| 08/09/2022 | MRSN | Buy Now | Mersana Therapeutics | $0.41 | 3313.8% | Jonathan Chang38% | $13 → $14 | Maintains | Outperform | Get Alert |
| 08/05/2022 | BCYC | Buy Now | Bicycle Therapeutics | $8.73 | 449.83% | Jonathan Chang38% | $69 → $48 | Maintains | Outperform | Get Alert |
| 08/05/2022 | REPL | Buy Now | Replimune Group | $10.40 | 255.77% | Jonathan Chang38% | $48 → $37 | Maintains | Outperform | Get Alert |
| 06/07/2022 | VINC | Buy Now | Vincerx Pharma | $0.59 | 917.29% | Jonathan Chang38% | $380 → $120 | Maintains | Outperform | Get Alert |
| 06/03/2022 | IMTX | Buy Now | Immatics | $4.53 | 473.95% | Jonathan Chang38% | $25 → $26 | Maintains | Outperform | Get Alert |
| 05/20/2022 | REPL | Buy Now | Replimune Group | $10.40 | 361.54% | Jonathan Chang38% | $49 → $48 | Maintains | Outperform | Get Alert |
| 05/13/2022 | VINC | Buy Now | Vincerx Pharma | $0.59 | 3121.43% | Jonathan Chang38% | $400 → $380 | Maintains | Outperform | Get Alert |
| 05/12/2022 | GMAB | Buy Now | Genmab | $19.66 | 52.59% | Jonathan Chang38% | $39 → $30 | Maintains | Market Perform | Get Alert |
| 05/11/2022 | ZLAB | Buy Now | Zai Lab | $33.91 | 180.15% | Jonathan Chang38% | $101 → $95 | Maintains | Outperform | Get Alert |
| 05/10/2022 | ATNX | Buy Now | Athenex | — | — | Jonathan Chang38% | $20 → $60 | Maintains | Market Perform | Get Alert |
| 05/10/2022 | RUBY | Buy Now | Rubius Therapeutics | — | — | Jonathan Chang38% | $2 → $3 | Maintains | Market Perform | Get Alert |
| 05/09/2022 | MRSN | Buy Now | Mersana Therapeutics | $0.41 | 3313.8% | Jonathan Chang38% | $13 → $14 | Maintains | Outperform | Get Alert |
| 05/09/2022 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.23 | 1210.04% | Jonathan Chang38% | $2 → $3 | Maintains | Market Perform | Get Alert |
| 05/06/2022 | IMGN | Buy Now | Immunogen | — | — | Jonathan Chang38% | $5 → $4 | Maintains | Market Perform | Get Alert |
| 05/06/2022 | BCYC | Buy Now | Bicycle Therapeutics | $8.73 | 690.38% | Jonathan Chang38% | $70 → $69 | Maintains | Outperform | Get Alert |
| 05/05/2022 | KPTI | Buy Now | Karyopharm Therapeutics | $5.60 | -10.71% | Jonathan Chang38% | $90 → $75 | Maintains | Market Perform | Get Alert |
| 05/04/2022 | MGNX | Buy Now | Macrogenics | $1.57 | 855.41% | Jonathan Chang38% | $23 → $15 | Maintains | Outperform | Get Alert |
| 04/21/2022 | ZLAB | Buy Now | Zai Lab | $33.91 | 197.85% | Jonathan Chang38% | $102 → $101 | Maintains | Outperform | Get Alert |
| 04/11/2022 | RUBY | Buy Now | Rubius Therapeutics | — | — | Jonathan Chang38% | $5 → $3 | Maintains | Market Perform | Get Alert |
| 04/04/2022 | CALA | Buy Now | Calithera Biosciences | $0.00 | 249900% | Jonathan Chang38% | $60 → $40 | Maintains | Outperform | Get Alert |
| 03/30/2022 | VINC | Buy Now | Vincerx Pharma | $0.59 | 3290.98% | Jonathan Chang38% | $480 → $400 | Maintains | Outperform | Get Alert |
| 03/24/2022 | IMTX | Buy Now | Immatics | $4.53 | 451.88% | Jonathan Chang38% | $32 → $25 | Maintains | Outperform | Get Alert |
| 03/23/2022 | TCRR | Buy Now | TCR2 Therapeutics | — | — | Jonathan Chang38% | $7 → $3 | Maintains | Market Perform | Get Alert |
| 03/17/2022 | ATNX | Buy Now | Athenex | — | — | Jonathan Chang38% | $40 → $60 | Maintains | Market Perform | Get Alert |
| 03/15/2022 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.23 | 1210.04% | Jonathan Chang38% | $7 → $3 | Maintains | Market Perform | Get Alert |
| 03/02/2022 | ZLAB | Buy Now | Zai Lab | $33.91 | 200.8% | Jonathan Chang38% | $194 → $102 | Maintains | Outperform | Get Alert |
| 03/02/2022 | KPTI | Buy Now | Karyopharm Therapeutics | $5.60 | 7.14% | Jonathan Chang38% | $120 → $90 | Maintains | Market Perform | Get Alert |
| 02/25/2022 | RUBY | Buy Now | Rubius Therapeutics | — | — | Jonathan Chang38% | $14 → $5 | Maintains | Market Perform | Get Alert |
| 02/25/2022 | KURA | Buy Now | Kura Oncology | $7.14 | 292.16% | Jonathan Chang38% | $41 → $28 | Maintains | Outperform | Get Alert |
| 02/25/2022 | MGNX | Buy Now | Macrogenics | $1.57 | 1364.97% | Jonathan Chang38% | $40 → $23 | Maintains | Outperform | Get Alert |
| 02/22/2022 | IMGN | Buy Now | Immunogen | — | — | Jonathan Chang38% | $7 → $5 | Maintains | Market Perform | Get Alert |
| 02/18/2022 | MRSN | Buy Now | Mersana Therapeutics | $0.41 | 3801.49% | Jonathan Chang38% | $25 → $16 | Maintains | Outperform | Get Alert |
| 02/17/2022 | GMAB | Buy Now | Genmab | $19.66 | 98.37% | Jonathan Chang38% | $42 → $39 | Maintains | Market Perform | Get Alert |
| 01/20/2022 | CALA | Buy Now | Calithera Biosciences | $0.00 | 374900% | Jonathan Chang38% | $20 → $60 | Upgrade | Market Perform → Outperform | Get Alert |
| 01/10/2022 | KPTI | Buy Now | Karyopharm Therapeutics | $5.60 | 42.86% | Jonathan Chang38% | $90 → $120 | Maintains | Market Perform | Get Alert |
| 12/17/2021 | BCYC | Buy Now | Bicycle Therapeutics | $8.73 | 701.83% | Jonathan Chang38% | → $70 | Initiates | → Outperform | Get Alert |
| 11/11/2021 | HARP | Buy Now | Harpoon Therapeutics | — | — | Jonathan Chang38% | $250 → $190 | Maintains | Outperform | Get Alert |
| 11/10/2021 | TCRR | Buy Now | TCR2 Therapeutics | — | — | Jonathan Chang38% | $8 → $7 | Maintains | Market Perform | Get Alert |
| 11/10/2021 | ZLAB | Buy Now | Zai Lab | $33.91 | 472.1% | Jonathan Chang38% | $200 → $194 | Maintains | Outperform | Get Alert |
| 11/09/2021 | RUBY | Buy Now | Rubius Therapeutics | — | — | Jonathan Chang38% | $20 → $14 | Maintains | Market Perform | Get Alert |
| 11/01/2021 | VINC | Buy Now | Vincerx Pharma | $0.59 | 3969.18% | Jonathan Chang38% | → $480 | Initiates | → Outperform | Get Alert |
| 10/29/2021 | IMGN | Buy Now | Immunogen | — | — | Jonathan Chang38% | $6 → $5 | Maintains | Market Perform | Get Alert |
| 10/21/2021 | TCRR | Buy Now | TCR2 Therapeutics | — | — | Jonathan Chang38% | $18 → $8 | Downgrade | Outperform → Market Perform | Get Alert |
| 09/13/2021 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.23 | 2956.77% | Jonathan Chang38% | $6 → $7 | Maintains | Market Perform | Get Alert |
| 09/07/2021 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.23 | 2520.09% | Jonathan Chang38% | $5 → $6 | Maintains | Market Perform | Get Alert |
| 08/23/2021 | REPL | Buy Now | Replimune Group | $10.40 | 371.15% | Jonathan Chang38% | $55 → $49 | Maintains | Outperform | Get Alert |
| 08/12/2021 | GMAB | Buy Now | Genmab | $19.66 | 113.63% | Jonathan Chang38% | $37 → $42 | Maintains | Market Perform | Get Alert |
| 08/12/2021 | RVMD | Buy Now | Revolution Medicines | $37.72 | 0.74% | Jonathan Chang38% | $46 → $38 | Maintains | Outperform | Get Alert |
| 08/10/2021 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.23 | 2083.41% | Jonathan Chang38% | $6 → $5 | Maintains | Market Perform | Get Alert |
| 08/09/2021 | REPL | Buy Now | Replimune Group | $10.40 | 428.85% | Jonathan Chang38% | $56 → $55 | Maintains | Outperform | Get Alert |
| 08/06/2021 | TCRR | Buy Now | TCR2 Therapeutics | — | — | Jonathan Chang38% | $34 → $31 | Maintains | Outperform | Get Alert |
| 08/06/2021 | ATNX | Buy Now | Athenex | — | — | Jonathan Chang38% | $100 → $80 | Maintains | Market Perform | Get Alert |
| 08/06/2021 | KPTI | Buy Now | Karyopharm Therapeutics | $5.60 | 7.14% | Jonathan Chang38% | → $90 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/06/2021 | HARP | Buy Now | Harpoon Therapeutics | — | — | Jonathan Chang38% | $290 → $250 | Maintains | Outperform | Get Alert |
| 08/06/2021 | KURA | Buy Now | Kura Oncology | $7.14 | 474.23% | Jonathan Chang38% | $40 → $41 | Maintains | Outperform | Get Alert |
| 08/05/2021 | XNCR | Buy Now | Xencor | $10.62 | 399.06% | Jonathan Chang38% | $57 → $53 | Maintains | Outperform | Get Alert |
| 07/15/2021 | IMTX | Buy Now | Immatics | $4.53 | 496.03% | Jonathan Chang38% | $26 → $27 | Maintains | Outperform | Get Alert |
| 06/01/2021 | ZLAB | Buy Now | Zai Lab | $33.91 | 495.69% | Jonathan Chang38% | $192 → $202 | Maintains | Outperform | Get Alert |
| 05/11/2021 | RVMD | Buy Now | Revolution Medicines | $37.72 | 21.95% | Jonathan Chang38% | $55 → $46 | Maintains | Outperform | Get Alert |
| 05/03/2021 | KPTI | Buy Now | Karyopharm Therapeutics | $5.60 | 167.86% | Jonathan Chang38% | $330 → $225 | Maintains | Outperform | Get Alert |
| 04/30/2021 | MGNX | Buy Now | Macrogenics | $1.57 | 2447.77% | Jonathan Chang38% | $37 → $40 | Maintains | Outperform | Get Alert |
| 04/14/2021 | ZLAB | Buy Now | Zai Lab | $33.91 | 466.2% | Jonathan Chang38% | $183 → $192 | Maintains | Outperform | Get Alert |
| 03/17/2021 | IMTX | Buy Now | Immatics | $4.53 | 473.95% | Jonathan Chang38% | $17 → $26 | Maintains | Outperform | Get Alert |
| 03/15/2021 | RUBY | Buy Now | Rubius Therapeutics | — | — | Jonathan Chang38% | $4 → $20 | Maintains | Market Perform | Get Alert |
| 03/11/2021 | TCRR | Buy Now | TCR2 Therapeutics | — | — | Jonathan Chang38% | $41 → $34 | Maintains | Outperform | Get Alert |
| 03/11/2021 | HARP | Buy Now | Harpoon Therapeutics | — | — | Jonathan Chang38% | $310 → $290 | Maintains | Outperform | Get Alert |
| 03/02/2021 | ATNX | Buy Now | Athenex | — | — | Jonathan Chang38% | $440 → $100 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/26/2021 | KURA | Buy Now | Kura Oncology | $7.14 | 460.22% | Jonathan Chang38% | $42 → $40 | Maintains | Outperform | Get Alert |
| 02/24/2021 | GMAB | Buy Now | Genmab | $19.66 | 83.11% | Jonathan Chang38% | $38 → $36 | Maintains | Market Perform | Get Alert |
| 02/23/2021 | RUBY | Buy Now | Rubius Therapeutics | — | — | Jonathan Chang38% | $5 → $4 | Maintains | Market Perform | Get Alert |
| 02/11/2021 | KPTI | Buy Now | Karyopharm Therapeutics | $5.60 | 292.86% | Jonathan Chang38% | $375 → $330 | Maintains | Outperform | Get Alert |
| 02/04/2021 | REPL | Buy Now | Replimune Group | $10.40 | 438.46% | Jonathan Chang38% | $57 → $56 | Maintains | Outperform | Get Alert |
| 02/03/2021 | ZLAB | Buy Now | Zai Lab | $33.91 | 457.36% | Jonathan Chang38% | $107 → $189 | Maintains | Outperform | Get Alert |
| 01/26/2021 | GMAB | Buy Now | Genmab | $19.66 | 93.29% | Jonathan Chang38% | $34 → $38 | Maintains | Market Perform | Get Alert |
| 01/12/2021 | KPTI | Buy Now | Karyopharm Therapeutics | $5.60 | 346.43% | Jonathan Chang38% | $435 → $375 | Maintains | Outperform | Get Alert |
| 01/05/2021 | CALA | Buy Now | Calithera Biosciences | $0.00 | 249900% | Jonathan Chang38% | $140 → $40 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/04/2021 | HARP | Buy Now | Harpoon Therapeutics | — | — | Jonathan Chang38% | $280 → $310 | Maintains | Outperform | Get Alert |
| 12/09/2020 | GMAB | Buy Now | Genmab | $19.66 | 72.94% | Jonathan Chang38% | $36 → $34 | Maintains | Market Perform | Get Alert |
| 11/09/2020 | MRSN | Buy Now | Mersana Therapeutics | $0.41 | 6727.6% | Jonathan Chang38% | $25 → $28 | Maintains | Outperform | Get Alert |
| 11/06/2020 | IMGN | Buy Now | Immunogen | — | — | Jonathan Chang38% | $5 → $6 | Maintains | Market Perform | Get Alert |
| 11/06/2020 | XNCR | Buy Now | Xencor | $10.62 | 333.15% | Jonathan Chang38% | $42 → $46 | Maintains | Outperform | Get Alert |
| 11/05/2020 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.23 | 2520.09% | Jonathan Chang38% | $10 → $6 | Maintains | Market Perform | Get Alert |
| 11/05/2020 | MGNX | Buy Now | Macrogenics | $1.57 | 2256.69% | Jonathan Chang38% | $38 → $37 | Maintains | Outperform | Get Alert |
| 11/03/2020 | KPTI | Buy Now | Karyopharm Therapeutics | $5.60 | 400% | Jonathan Chang38% | $450 → $420 | Maintains | Outperform | Get Alert |
| 10/26/2020 | ATNX | Buy Now | Athenex | — | — | Jonathan Chang38% | → $440 | Initiates | → Outperform | Get Alert |
| 10/15/2020 | REPL | Buy Now | Replimune Group | $10.40 | 323.08% | Jonathan Chang38% | $27 → $44 | Maintains | Outperform | Get Alert |
| 10/06/2020 | IMGN | Buy Now | Immunogen | — | — | Jonathan Chang38% | $4 → $5 | Maintains | Market Perform | Get Alert |
| 09/21/2020 | MGNX | Buy Now | Macrogenics | $1.57 | 2320.38% | Jonathan Chang38% | $35 → $38 | Maintains | Outperform | Get Alert |
| 09/10/2020 | ZLAB | Buy Now | Zai Lab | $33.91 | 180.15% | Jonathan Chang38% | $93 → $95 | Maintains | Outperform | Get Alert |
| 09/08/2020 | GMAB | Buy Now | Genmab | $19.66 | 78.03% | Jonathan Chang38% | → $35 | Initiates | → Market Perform | Get Alert |
| 09/08/2020 | XNCR | Buy Now | Xencor | $10.62 | 267.23% | Jonathan Chang38% | $42 → $39 | Maintains | Outperform | Get Alert |
| 08/12/2020 | TCRR | Buy Now | TCR2 Therapeutics | — | — | Jonathan Chang38% | $26 → $25 | Maintains | Outperform | Get Alert |
| 08/11/2020 | CALA | Buy Now | Calithera Biosciences | $0.00 | 874900% | Jonathan Chang38% | $180 → $140 | Maintains | Outperform | Get Alert |
| 08/10/2020 | RVMD | Buy Now | Revolution Medicines | $37.72 | 3.39% | Jonathan Chang38% | $40 → $39 | Maintains | Outperform | Get Alert |
| 08/07/2020 | REPL | Buy Now | Replimune Group | $10.40 | 159.62% | Jonathan Chang38% | $25 → $27 | Maintains | Outperform | Get Alert |
| 08/06/2020 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.23 | 4266.81% | Jonathan Chang38% | $11 → $10 | Maintains | Market Perform | Get Alert |
| 08/05/2020 | XNCR | Buy Now | Xencor | $10.62 | 295.48% | Jonathan Chang38% | $44 → $42 | Maintains | Outperform | Get Alert |
| 08/04/2020 | KPTI | Buy Now | Karyopharm Therapeutics | $5.60 | 435.71% | Jonathan Chang38% | $465 → $450 | Maintains | Outperform | Get Alert |
| 07/27/2020 | IMTX | Buy Now | Immatics | $4.53 | 275.28% | Jonathan Chang38% | → $17 | Initiates | → Outperform | Get Alert |
| 05/29/2020 | MGNX | Buy Now | Macrogenics | $1.57 | 1619.75% | Jonathan Chang38% | $15 → $27 | Maintains | Outperform | Get Alert |
| 05/27/2020 | MRSN | Buy Now | Mersana Therapeutics | $0.41 | 5020.7% | Jonathan Chang38% | $12 → $21 | Reiterates | → Outperform | Get Alert |
| 05/06/2020 | MGNX | Buy Now | Macrogenics | $1.57 | 855.41% | Jonathan Chang38% | $16 → $15 | Reiterates | → Outperform | Get Alert |
| 05/05/2020 | KPTI | Buy Now | Karyopharm Therapeutics | $5.60 | 417.86% | Jonathan Chang38% | $450 → $435 | Maintains | Outperform | Get Alert |
| 05/07/2019 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.23 | — | Jonathan Chang38% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/10/2018 | ARMO | Buy Now | ARMO BioSciences, Inc. - Common Stock | — | — | Jonathan Chang38% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/28/2018 | XNCR | Buy Now | Xencor | $10.62 | 238.98% | Jonathan Chang38% | → $36 | Assumes | Outperform → Outperform | Get Alert |
| 03/27/2018 | ARMO | Buy Now | ARMO BioSciences, Inc. - Common Stock | — | — | Jonathan Chang38% | → $50 | Assumes | Market Perform → Outperform | Get Alert |
| 03/10/2016 | XNCR | Buy Now | Xencor | $10.62 | 69.49% | Jonathan Chang38% | $22 → $18 | Maintains | Outperform | Get Alert |
| 03/08/2016 | XNCR | Buy Now | Xencor | $10.62 | 69.49% | Jonathan Chang38% | $22 → $18 | Maintains | Outperform | Get Alert |
